Effect of aging on biomarkers and clinical profile in Parkinson’s disease

Our data support the hypothesis that PD has different underlying biological features in younger and older subjects. Older subjects may have a broader spectrum of disease mechanisms, reflected in the higher prevalence of amyloid pathology and neurodegeneration, which could underlie the worse cognitive performances and lower dyskinesia burden. They could therefore necessitate a wider array of treatment strategies along with dopaminergic supplementation. Consequently, some of these biomarkers hold promise in refining treatment approaches in PD.

Authors

Institutions

Publication Details

Journal
Journal of Neurology
Published
2025-09-24
DOI
https://doi.org/10.1007/s00415-025-13384-7
Citations
3
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
4.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of aging on biomarkers and clinical profile in Parkinson’s disease

Guido Maria Giuffrè, Piergiorgio Grillo, Lucilla Parnetti, Giulia Di Lazzaro et al.
3 citations
Journal of Neurology
Parkinson's Disease Mechanisms and Treatments
4.17
article

Effect of aging on biomarkers and clinical profile in Parkinson’s disease

Guido Maria Giuffrè, Piergiorgio Grillo, Lucilla Parnetti, Giulia Di Lazzaro, Anna Rita Bentivoglio, Tommaso Schirinzi, Federico Paolini Paoletti, Anna Picca, Giovanni Bellomo, Nicola Biagio Mercuri, Paolo Calabresi, Martina Petracca
article en
3 citations

Abstract

Our data support the hypothesis that PD has different underlying biological features in younger and older subjects. Older subjects may have a broader spectrum of disease mechanisms, reflected in the higher prevalence of amyloid pathology and neurodegeneration, which could underlie the worse cognitive performances and lower dyskinesia burden. They could therefore necessitate a wider array of treatment strategies along with dopaminergic supplementation. Consequently, some of these biomarkers hold promise in refining treatment approaches in PD.

Journal of NeurologyVol. 272(10)
Università Cattolica del Sacro Cuore (IT), University of Rome Tor Vergata (IT), University of Pavia (IT), University of Perugia (IT), Agostino Gemelli University Polyclinic (IT), LUM Jean Monnet University (IT)
Ministero dell’Istruzione, dell’Università e della Ricerca
Openalex Percentile: Top 5%
Parkinson's Disease Mechanisms and Treatments
4.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effect of aging on biomarkers and clinical profile in Parkinson’s disease — Guido Maria Giuffrè, Piergiorgio Grillo, et al. · Journal of Neurology (2025) | TGRS Research Map | TGRS